The evaluated parameters included tumor size, prolactin (PRL) levels, and clinical symptomatology.<h4>Results</h4>A total of 160 women with idiopathic HPRL, micro- or macroadenomas, with symptom onset at 29.3±9.0 years, were included. This evidence concerns the gene PRL and neoplasm.